Literature DB >> 27005988

Cortical Development Requires Mesodermal Expression of Tbx1, a Gene Haploinsufficient in 22q11.2 Deletion Syndrome.

Gemma Flore1, Sara Cioffi1,2, Marchesa Bilio1, Elizabeth Illingworth1,3.   

Abstract

In mammals, proper temporal control of neurogenesis and neural migration during embryonic development ensures correct formation of the cerebral cortex. Changes in the distribution of cortical projection neurons and interneurons are associated with behavioral disorders and psychiatric diseases, including schizophrenia and autism, suggesting that disrupted cortical connectivity contributes to the brain pathology. TBX1 is the major candidate gene for 22q11.2 deletion syndrome (22q11.2DS), a chromosomal deletion disorder characterized by a greatly increased risk for schizophrenia. We have previously shown that Tbx1 heterozygous mice have reduced prepulse inhibition, a behavioral abnormality that is associated with 22q11.2DS and nonsyndromic schizophrenia. Here, we show that loss of Tbx1 disrupts corticogenesis in mice by promoting premature neuronal differentiation in the medio-lateral embryonic cortex, which gives rise to the somatosensory cortex (S1). In addition, we found altered polarity in both radially migrating excitatory neurons and tangentially migrating inhibitory interneurons. Together, these abnormalities lead to altered lamination in the S1 at the terminal stages of corticogenesis in Tbx1 null mice and similar anomalies in Tbx1 heterozygous adult mice. Finally, we show that mesoderm-specific inactivation of Tbx1 is sufficient to recapitulate the brain phenotype indicating that Tbx1 exerts a cell nonautonomous role in cortical development from the mesoderm.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  22q11.2 deletion syndrome; S1 cortex; Tbx1; animal model; cortical development

Mesh:

Substances:

Year:  2017        PMID: 27005988     DOI: 10.1093/cercor/bhw076

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  6 in total

Review 1.  Neurobiological perspective of 22q11.2 deletion syndrome.

Authors:  Janneke R Zinkstok; Erik Boot; Anne S Bassett; Noboru Hiroi; Nancy J Butcher; Claudia Vingerhoets; Jacob A S Vorstman; Therese A M J van Amelsvoort
Journal:  Lancet Psychiatry       Date:  2019-08-05       Impact factor: 27.083

2.  Screening for Mutations in the TBX1 Gene on Chromosome 22q11.2 in Schizophrenia.

Authors:  Lieh-Yung Ping; Yang-An Chuang; Shih-Hsin Hsu; Hsin-Yao Tsai; Min-Chih Cheng
Journal:  Genes (Basel)       Date:  2016-11-22       Impact factor: 4.096

3.  Identification of a Novel ENU-Induced Mutation in Mouse Tbx1 Linked to Human DiGeorge Syndrome.

Authors:  Jiaofeng Chen; Xue Zhang; Jie Li; Chenmeng Song; Yichang Jia; Wei Xiong
Journal:  Neural Plast       Date:  2016-12-26       Impact factor: 3.599

4.  Pharmacological Rescue of the Brain Cortex Phenotype of Tbx1 Mouse Mutants: Significance for 22q11.2 Deletion Syndrome.

Authors:  Ilaria Favicchia; Gemma Flore; Sara Cioffi; Gabriella Lania; Antonio Baldini; Elizabeth Illingworth
Journal:  Front Mol Neurosci       Date:  2021-09-06       Impact factor: 5.639

5.  Transamniotic mesenchymal stem cell therapy for neural tube defects preserves neural function through lesion-specific engraftment and regeneration.

Authors:  Xiaowei Wei; Wei Ma; Hui Gu; Dan Liu; Wenting Luo; Yuzuo Bai; Weilin Wang; Vincent Chi Hang Lui; Peixin Yang; Zhengwei Yuan
Journal:  Cell Death Dis       Date:  2020-07-13       Impact factor: 8.469

6.  Periventricular nodular heterotopia in 22q11.2 deletion and frontal lobe migration.

Authors:  Arezoo Rezazadeh; Eduard Bercovici; Tim-Rasmus Kiehl; Eva W Chow; Timo Krings; Anne S Bassett; Danielle M Andrade
Journal:  Ann Clin Transl Neurol       Date:  2018-09-23       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.